FDA Licenses First-Ever Freeze-Dried Plasma Product in U.S.
SILVER SPRING, Md., July 29, 2026 The U.S. Food and Drug Administration (FDA) has licensed Ezplaz Freeze Dried Plasma...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SILVER SPRING, Md., July 29, 2026 The U.S. Food and Drug Administration (FDA) has licensed Ezplaz Freeze Dried Plasma...
NANJING, China, August 3, 2026 Leads Biolabs announced that the Center for Drug Evaluation (CDE) of China’s National Medical...
CULVER CITY, Calif., July 28, 2026 Avenda Health announced that its FDA-cleared Unfold AI platform is now being used...
